Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer
Open Access
- 1 July 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 929832
Abstract
Ferroptosis, a new way of cell death, is involved in many cancers. A growing number of studies have focused on the unique role of ferroptosis on endometrial cancer. In this study, we made a comprehensive review of the relevant articles published to get deep insights in the association of ferroptosis with endometrial cancer and to present a summary of the roles of different ferroptosis-associated genes. Accordingly, we made an evaluation of the relationships between the ferroptosis-associated genes and TNM stage, tumor grade, histological type, primary therapy outcome, invasion and recurrence of tumor, and accessing the different prognosis molecular typing based on ferroptosis-associated genes. In addition, we presented an introduction of the common drugs, which targeted ferroptosis in endometrial cancer. In so doing, we clarified the opportunities and challenges of ferroptosis activator application in treating endometrial cancer, with a view to provide a novel approach to the disease.Keywords
Funding Information
- Shanghai Municipal Health Commission
- Shanghai Pudong New Area Health Commission (PWRd2021-13)
- Shanghai University of Medicine and Health Sciences
This publication has 133 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Surveillance Procedures for Patients Treated for Endometrial CancerInternational Journal of Gynecological Cancer, 2010
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant functionProceedings of the National Academy of Sciences, 2010
- A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II ConsortiaGynecologic Oncology, 2010
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanismsEuropean Journal of Cancer, 2010
- Dietary Iron Intake and Risk of Endometrial Cancer: A Population-Based Case-Control Study in Shanghai, ChinaNutrition and Cancer, 2009
- S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signalingLaboratory Investigation, 2009
- Lipophilic but not hydrophilic statins selectively induce cell death in gynecological cancers expressing high levels of HMGCoA reductase.Journal of Cellular and Molecular Medicine, 2009
- Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort studyBritish Journal of Cancer, 2007
- Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature reviewInternational Journal of Gynecological Cancer, 2004